Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency Advocacy Hub | UniteRare

At a Glance

Live from database

🩺

1Specialists

Regulatory Watchboard

2 events

Dec 2026ENA-001 for Post Operative Respiratory Depression (PORD)

Enalare Therapeutics Inc. — PHASE2

TrialNOT YET RECRUITING

Jan 2020Iodine Impact on Thyroid Function and Psychomotor Development, Observational Study in the Portuguese Minho Region

University of Minho

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency.
Search all trials →

Search clinical trials for Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency →